Details of the Drug

General Information of Drug (ID: DMEF5UT)

• Drug Name: GRN 1201

Indication

Disease Entry	ICD 11	Status	REF
Non-small-cell lung cancer	2C25.Y	Phase 2	[1]
Melanoma	2C30	Phase 1	[2]

• Drug Type: Vaccine
• Cross-matching ID: TTD ID: D3JN6C
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT03417882) GRN-1201 With Pembrolizumab in Subjects With Metastatic PD-L1+ NSCLC. U.S. National Institutes of Health.
• [2] ClinicalTrials.gov (NCT02696356) Phase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected Melanoma. U.S. National Institutes of Health.